On 14 MAY AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced that a FDA panel recommended its drug Tivopath not be approved as a treatment for advanced kidney cancer. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) and Astellas Pharma Inc. said that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee voted that the application for investigational agent tivozanib did not demonstrate a favorable benefit-to-risk evaluation for the treatment of advanced renal cell carcinoma (RCC) in an adequate and wellcontrolled trial (13 to 1, 0 abstentions). AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) weekly performance is -7.76%. On last trading day company shares ended up $1.07. Analysts mean target price for the company is $1.67. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) distance from 50-day simple moving average (SMA50) is -22.02%.
On 23 MAY Acasti Pharma Inc (NASDAQ:ACST) jointly announce the appointment of Andre Godin as interim President and Chief Executive Officer of Neptune, Acasti and NeuroBio with immediate effect. Acasti Pharma Inc (NASDAQ:ACST) shares fell -2.30% in last trading session and ended the day on $0.850. Acasti Pharma Inc (NASDAQ:ACST) quarterly performance is -36.09%.
Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG announced that, based upon data from its Phase 1b study of birinapant in combination with azacitidine in patients with relapsed/refractory or naïve higher risk MDS, it selected a dose of 13mg/m2 twice weekly for three weeks out of four to be used in its Phase 2 clinical trial. Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) shares moved down -3.84% in last trading session and was closed at $4.01, while trading in range of $3.84 – $4.30. Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) year to date (YTD) performance is -57.88%.
Roche Holding Ltd. (ADR) (OTCMKTS: RHHBY) received positive news when the Committee for Medicinal Products for Human Use (CHMP) recommended the European Commission to approve Gazyvaro in combination with chlorambucil for the treatment of adult patients suffering from previously untreated chronic lymphocytic leukemia (CLL).Roche Holding Ltd. (ADR) (OTCMKTS: RHHBY) ended the last trading day at $37.19.
On 23 MAY CEO of Russia’s Gazprom OAO (ADR) (OTCMKTS: OGZPY) said the agreement to supply natural gas to China will influence prices in Europe and have an overall affect on international liquefied natural gas projects, according to Reuters. Gazprom OAO (ADR) (OTCMKTS: OGZPY) on last trading day company shares ended up $8.23.